Abstract
Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.
Original language | English (US) |
---|---|
Pages (from-to) | 62-70 |
Number of pages | 9 |
Journal | Special Care in Dentistry |
Volume | 37 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2017 |
Externally published | Yes |
Keywords
- anticoagulation
- medical management
- pharmacy
- surgery
ASJC Scopus subject areas
- General Dentistry